traccglobal.com

Our Services

Medical Device Registration in Saudi Arabia (SFDA Approval)

Turnkey Project Services

Medical Device Registration in Saudi Arabia is the process of obtaining a Medical Device Marketing Authorization (MDMA) from the Saudi Food and Drug Authority (SFDA) — the country’s apex regulatory body — before any medical device or IVD can be legally sold or distributed in the Kingdom. The SFDA full form is Saudi Food and Drug Authority. Since January 2022, all devices must follow the MDMA2 route, which requires submission of a complete Technical File Assessment (TFA) through the SFDA’s GHAD online portal. Devices are classified into four risk classes (A, B, C, D), and an in-country Authorized Representative (AR) is mandatory for all foreign manufacturers. The MDMA certificate is valid for up to 3 years and must be renewed before expiry. The process aligns closely with EU MDR standards, making it accessible for companies that already hold CE Marking — though Saudi-specific documentation adjustments are required. Traccglobal provides end-to-end medical device regulatory support for SFDA approval, including AR services, full dossier preparation, GHAD portal submissions, and post-market compliance.

What is SFDA? Understanding Saudi Arabia Medical Device Regulations

The SFDA full form is Saudi Food and Drug Authority — the Kingdom of Saudi Arabia’s national regulatory body responsible for overseeing the safety, quality, and performance of food, drugs, and medical devices. The Saudi food and drug authority was established under the Council of Ministers and operates with three core mandates: legislative, executive, and market surveillance.

The Saudi food and drug authority (SFDA) governs medical devices under its Medical Devices Sector (MDS), which is responsible for registering all medical devices and IVDs before they can enter the Saudi market. The SFDA is a member of the International Medical Device Regulators Forum (IMDRF), which means its standards are aligned with global best practices.

The Saudi Arabia medical device regulations are primarily governed by the Medical Devices and Supplies Regulation, which came into effect in 2021. This law draws heavily from the European Union Medical Device Regulation (MDR), making the process familiar for manufacturers who already hold CE Marking.

Saudi Arabia is the largest medical device market in the Middle East, driven by rapid population growth, rising healthcare expenditure, and Vision 2030 investments in the health sector. For any medical device company looking to expand into the Gulf Cooperation Council (GCC) region, getting medical device registration in Saudi Arabia through the SFDA is the most important first step.

Why Medical Device Registration in Saudi Arabia Matters in 2026

Saudi Arabia is not just another market — it is the gateway to the entire GCC region. Here is why manufacturers and importers are prioritising SFDA approval right now:

Largest GCC Healthcare Market

Saudi Arabia’s healthcare sector is valued at over USD 25 billion and is growing rapidly, fueled by Vision 2030 investments. SFDA registration opens doors across the entire GCC — UAE, Kuwait, Bahrain, Oman, and Qatar.

CE-Aligned Regulations

SFDA’s Saudi Arabia medical device regulations are built on EU MDR standards. If you have CE Marking documentation, the technical file structure translates well — with Traccglobal’s expert adaptation for Saudi-specific requirements.

Rising Healthcare Demand

Saudi Arabia is investing heavily in new hospitals, diagnostic labs, and specialised care facilities. Government tenders and hospital procurement require valid SFDA approval — without it, you are locked out of billions in contracts.

Legal Mandatory Requirement

No medical device or IVD can be legally imported, distributed, or sold in Saudi Arabia without a valid MDMA certificate from the Saudi food and drug authority. Non-compliance leads to product seizure and legal penalties.

Easier GCC Market Entry

SFDA registration is often the first step to entering other GCC markets. Many neighbouring countries recognise SFDA approval and use it as a reference, significantly reducing timelines for regional expansion.

3-Year MDMA Validity

An approved MDMA certificate under the current Saudi route is valid for 3 years, providing a stable window to build your market presence and distribution network before renewal.

Medical Device Classification Under SFDA Saudi Arabia

The SFDA classifies all medical devices into four risk-based classes — A, B, C, and D — using 22 classification rules (for medical devices) and 7 classification rules (for IVDs), directly mirroring the EU MDR framework. Getting your device classification right is critical — wrong classification is the single most common reason for SFDA application delays.

Device Class Risk Level Device Examples Key Requirement Typical Timeline
Class A Lowest Risk Bandages, cotton gauze, tongue depressors, non-sterile gloves, manual wheelchairs Simplified Technical File; Post-Market Surveillance Report required 2–4 months
Class B Low–Medium Risk Blood pressure monitors, infusion pumps, surgical gloves, ultrasound gel, ECG electrodes Full Technical File; ISO 13485 certificate required; PSUR every 2 years 4–6 months
Class C Medium–High Risk Dialysis machines, blood glucose monitors, ventilators, pacemaker programmers Full TFA with clinical evaluation; PSUR annually; PMCF required 6–9 months
Class D Highest Risk Coronary stents, implantable pacemakers, spinal implants, heart valves Most stringent TFA; Summary of Safety & Clinical Performance; Annual PSUR; Possible site audit 9–14 months

SFDA Medical Device Registration Routes in 2026

The SFDA previously had two pathways — GHTF Route (accepting reference country approval) and the Saudi Route. Since January 2022, only the Saudi Route (MDMA2) is active for all new submissions. Understanding this is critical before you begin.

✔ MDMA2 — Saudi Route (Currently Active)

This is the only valid registration pathway for medical device registration in Saudi Arabia from January 2022 onwards. It requires submission of a complete Technical File Assessment (TFA) through the SFDA's GHAD portal. CE Marking or US FDA approval is not required but helps support your clinical data. The SFDA conducts an independent review of the full technical documentation.

  • Applicable to all device classes (A, B, C, D)
  • ISO 13485 QMS certificate is mandatory (even for Class A)
  • Complete Technical Documentation File required
  • GHAD portal submission by Authorized Representative
  • MDMA certificate valid for 3 years
  • Up to 50 devices can be bundled in a single application (same class, same manufacturer, same intended use)
✖ GHTF Route — Discontinued

This older route accepted approvals from GHTF reference countries (EU, USA, Canada, Australia, Japan) as the basis for SFDA registration. It was discontinued at the end of 2021. All previously registered devices under this route must now be migrated to MDMA2 upon renewal.

💡 Traccglobal Tip: If your device already has CE Marking or US FDA 510(k) clearance, Traccglobal uses your existing clinical evaluation, post-market data, and QMS documentation as the foundation — significantly reducing the time and cost of building your SFDA TFA from scratch.

SFDA Approval Process — How Medical Device Registration in Saudi Arabia Works

Here is the complete, step-by-step SFDA medical device registration process that Traccglobal manages for its clients. Each step is handled by our dedicated regulatory team — you focus on your business, we handle the compliance.

Step 1 —  Device Classification & Regulatory Strategy 

We begin with a thorough review of your device’s intended use, mechanism of action, and risk profile to confirm the correct SFDA classification (Class A to D or IVD class). We also assess your existing regulatory approvals (CE, US FDA, etc.) and design a strategy that minimises cost and timeline. Incorrect classification at this stage means wasted time and money — our experts eliminate that risk from Day

Step 2 — Appoint an Authorized Representative (AR) in Saudi Arabia

All foreign manufacturers must appoint a licensed Authorized Representative (AR) in the Kingdom of Saudi Arabia. The AR holds an annual-renewable AR license from the SFDA, legally represents you before the Saudi food and drug authority, submits your application on the GHAD portal, and is responsible for all post-market communications. Traccglobal provides full AR services through our Saudi Arabia partners — protecting your IP while ensuring full regulatory accountability.

Step 3 — Technical File Assessment (TFA) Preparation

This is the most critical and complex step. The SFDA Technical File closely mirrors the EU MDR Annex II Technical Documentation. Our team prepares the complete dossier, which includes:

  • Device description: Drawings, diagrams, materials, intended use, indications, patient populations, UDI
  • Design and Manufacturing information: Technical drawings, specifications, design history, manufacturing process
  • Labeling and IFU: Arabic and English labels, instructions for use, packaging compliance
  • ISO 13485:2016 Certificate + Audit report (mandatory for all classes)
  • Clinical Evaluation Report (CER): Adequate clinical evidence demonstrating safety and efficacy
  • Biocompatibility Testing (ISO 10993): For devices with patient contact
  • Electrical safety, EMC, Software validation (as applicable)
  • Sterilization and shelf-life validation (if sterile)
  • Post-Market Surveillance (PMS) Plan
  • Risk Management File (ISO 14971)
  • PSUR / Summary of Safety and Clinical Performance (Class C, D)
Step 4 —  GHAD Portal Submission

The SFDA uses an electronic submission system called the GHAD portal. Your AR submits the complete MDMA application, all technical documentation, and required forms through GHAD. Traccglobal manages the entire portal process — account setup, document uploads, completeness checks, and fee payment — ensuring zero errors that could trigger rejection.

Step 5 —  SFDA Completeness Review & Assessment Fee Payment

The SFDA conducts an initial completeness check of the submitted dossier. Once cleared, assessment fees are paid and the application moves to the formal regulatory review stage. Medical device registration fees in Saudi Arabia vary by device class — Traccglobal provides a precise fee estimate before you apply.

Step 6 — SFDA Regulatory Review & Query Management

The official SFDA review period is 35 working days, but actual timelines typically range from 3 to 9 months depending on device class and documentation completeness. During review, SFDA may raise Additional Information Requests (AIRs). Responding quickly — ideally within 10 days — is critical to avoid delays. Traccglobal’s team resolves all SFDA queries within 48 hours with zero ambiguity.

Step 7 — Site Audit (For Class C & D Devices, if required)

For high-risk Class C and D devices, the SFDA reserves the right to conduct an on-site audit of the manufacturing facility. Traccglobal prepares your team and facility documentation fully before any audit — addressing non-conformities before they become formal rejections.

Step 8 — MDMA Certificate Issued — Saudi Arabia Market Access

Once approved, the SFDA issues the Medical Device Marketing Authorization (MDMA) certificate in both Arabic and English. The certificate includes your device’s National Listing Number, certificate number, and 3-year validity period. You are now legally authorised to market and sell your device across Saudi Arabia. Traccglobal continues to support your post-market obligations — PSUR submissions, adverse event reporting, UDI compliance, and timely renewal.

Key Documents for SFDA Medical Device Registration

A complete and accurate Technical File is the single most important factor in getting fast SFDA approval. Here is a summary of what the Saudi food and drug authority requires:

Document Class A Class B Class C Class D
Device Description & Identification ✅ ✅ ✅ ✅
Labeling & IFU (English + Arabic) ✅ ✅ ✅ ✅
ISO 13485 Certificate + Last Audit Report ✅ ✅ ✅ ✅
Design & Manufacturing Information Abbreviated ✅ ✅ ✅
Risk Management File (ISO 14971) — ✅ ✅ ✅
Clinical Evaluation Report (CER) — ✅ ✅ ✅
Biocompatibility Testing (ISO 10993) — As applicable ✅ ✅
Electrical Safety / EMC / Software Validation — As applicable ✅ ✅
Post-Market Surveillance Plan & Report PMS Report PSUR (2yr) PSUR (Annual) PSUR (Annual)
Summary of Safety & Clinical Performance (SSCP) — — — ✅
Unique Device Identifier (UDI) Information ✅ ✅ ✅ ✅

Traccglobal prepares every document from scratch or adapts your existing CE/FDA documentation to SFDA standards. We review, gap-fill, and quality-check every file before submission.

How Traccglobal Has Helped Clients Get SFDA Approval

These are real regulatory challenges our clients faced when pursuing medical device registration in Saudi Arabia — and how Traccglobal’s team resolved them. Client identities are kept confidential for privacy.

DE German Orthopaedic Manufacturer Class D — Spinal Implants MDMA2 Route
Challenge: EU MDR Documentation Did Not Map to SFDA Requirements

A German manufacturer of spinal implant systems (Class D) came to Traccglobal after spending 6 months trying to self-manage their SFDA TFA. Their clinical evaluation was structured entirely for EU MDR Annex XIV — which did not directly satisfy SFDA's MDS-REQ-001 requirements. The SFDA had already raised 11 queries on their GHAD submission, and they were facing the risk of full rejection.

Traccglobal took over as their regulatory partner. We restructured the entire clinical evaluation to align with SFDA's specific requirements, reformatted the risk management file per ISO 14971 to SFDA's preferred structure, and rewrote the IFU in Arabic. All 11 SFDA queries were resolved in a single comprehensive response cycle within 8 working days. A manufacturing site audit was coordinated and passed on the first attempt.

✔ Outcome: MDMA certificate issued for a portfolio of 6 Class D spinal implant systems. Client entered the Saudi market within 13 months total — despite the earlier 6-month setback. Saudi distributor network established in 3 major hospital chains in Riyadh and Jeddah.
KR South Korean IVD Manufacturer Class C — Immunoassay Analysers IVD Registration
Challenge: IVD Classification Error & Incomplete Performance Evaluation

A South Korean diagnostics company producing Class C immunoassay analysers approached Traccglobal after their initial SFDA submission was flagged for incorrect IVD classification and an incomplete performance evaluation. They had applied under the wrong IVD class, which meant their entire fee payment and partial documentation needed to be redone.

Traccglobal conducted a fresh classification review under SFDA's 7-rule IVD classification framework and confirmed the correct class. We rebuilt the performance evaluation with analytical and clinical performance data specific to SFDA requirements, and prepared the full GHAD submission with bundled documentation for their product range. No additional queries were raised during SFDA review.

✔ Outcome: MDMA approval secured in 5 months. Client's analysers are now supplied to 8 diagnostic laboratory chains across Saudi Arabia and Kuwait.
IN Indian Medical Device Startup Class B — Wound Care Products First International Registration
Challenge: No International Regulatory Experience, No AR in Saudi Arabia

A Pune-based startup with a Class B wound care product line wanted to enter the Saudi market as their first international expansion. They had no regulatory experience outside India, no understanding of Saudi Arabia medical device regulations, and no in-country Authorized Representative. They came to Traccglobal 3 months before their targeted launch date — a timeline that most firms would call impossible.

Traccglobal acted as their end-to-end medical device regulatory support partner. We onboarded their Saudi AR within 2 weeks, conducted a full gap analysis of their CDSCO documentation vs. SFDA requirements, prepared the complete TFA from their existing ISO 13485 and CDSCO files, handled all GHAD portal submissions, and managed two SFDA queries proactively.

✔ Outcome: MDMA certificate received in 6.5 months. The startup successfully entered the Saudi market and signed a distribution agreement with a Riyadh-based distributor valued at SAR 1.8 million in Year 1.

5 Costly Mistakes That Delay SFDA Medical Device Registration

After supporting 200+ global clients with medical device regulatory support, Traccglobal has identified the most common errors that stall or sink SFDA applications.

Wrong Device Classification

Applying under the wrong class means paying the wrong fees, submitting wrong documentation, and facing outright rejection. SFDA classification requires interpreting 22 rules — not simply copy-pasting the CE class.

Incomplete Clinical Evaluation

The most common SFDA query reason. Clinical evaluation must meet SFDA-specific standards — not just EU MDR. Missing clinical data, wrong format, or lack of Saudi-relevant evidence triggers immediate queries.

No Valid Authorized Representative

Many companies appoint an AR without verifying their SFDA-issued AR license is current and valid. An AR with an expired or non-existent license means your entire application is void from the start.

Slow Response to SFDA Queries

SFDA requests additional information that must be responded to promptly. Companies without a dedicated regulatory team lose weeks — or face rejection — simply because query responses were delayed beyond SFDA's expectations.

Labeling Not in Arabic

Home-use medical device labels must be in Arabic. Professional-use labels must be at minimum in English. Many submissions are flagged because IFU or packaging labels fail this dual-language requirement.

✓
The Traccglobal Difference

Traccglobal eliminates all five of these risks through expert classification, thorough dossier review, verified AR partnerships, 48-hour query resolution, and bilingual labeling support — before a single document is submitted.

Why Choose Traccglobal for Medical Device Regulatory Support in Saudi Arabia?

Traccglobal is not a generic regulatory firm. We are specialists in medical device and IVD regulatory compliance across India and global markets including Saudi Arabia. Here is what makes us different from every other consultant claiming to offer SFDA registration services:

🎯
Dedicated SFDA Regulatory Team

Our Saudi Arabia regulatory team includes specialists who understand SFDA's MDS-REQ-001 framework, GHAD portal requirements, and current Saudi Arabia medical device regulations in 2026 — not outdated information from 3 years ago.

🤝
In-Country Authorized Representative Network

We have verified, SFDA-licensed AR partners in Riyadh. You get a single point of contact — Traccglobal — who manages both the regulatory work and the in-country legal representation, with no hand-off confusion.

📁
Zero-Error Technical File Preparation

Our 98% first-attempt approval rate is built on thorough, SFDA-specific documentation. We do not submit until every section of the TFA is complete, accurate, and reviewed by a senior expert.

⚡
48-Hour SFDA Query Resolution

SFDA queries demand fast, precise responses. Our team is structured to resolve any information request within 48 hours — preventing the delays that cost most companies 3–6 additional months.

🔄
CE & CDSCO to SFDA Conversion Expertise

If you already have CE Marking or CDSCO registration, Traccglobal can convert and adapt your existing documentation for SFDA submission — dramatically reducing the cost and time of building a Saudi TFA from zero.

🌐
Multi-Market Regulatory Strategy

Traccglobal helps you register across India (CDSCO), Europe (CE), USA (FDA 510k), and Saudi Arabia (SFDA) in parallel — building a global regulatory strategy that maximises market reach with minimal duplication of effort.

Our Service
What Traccglobal Does For You
Device Classification Advisory
Confirm correct SFDA class (A/B/C/D or IVD) before any fee or dossier cost
Authorized Representative (AR) Services
Provide or connect verified, SFDA-licensed AR in Saudi Arabia
Full TFA Preparation
Device description, design & mfg info, clinical evaluation, labeling, ISO 13485, biocompatibility, risk file
GHAD Portal Management
Account setup, document upload, fee management, completeness review, submission
SFDA Query Management
48-hour resolution of all Additional Information Requests — zero delays
Arabic Labeling & IFU
Bilingual (Arabic + English) labeling preparation per SFDA requirements
ISO 13485 QMS Support
Build or align your QMS with SFDA's SFDA.MD/GSO ISO 13485 requirements
Post-Market Compliance
PSUR preparation, adverse event reporting to NCMDR, UDI compliance, renewal management
Site Audit Preparation
Facility and documentation audit-readiness for Class C/D SFDA site inspections
Multi-Country Strategy
Combine SFDA with CE, CDSCO, US FDA — one integrated global regulatory roadmap

Frequently Asked Questions (FAQ) — Medical Device Registration in Saudi Arabia

What is SFDA full form and what does it regulate in Saudi Arabia?
SFDA full form is Saudi Food and Drug Authority. It is Saudi Arabia’s national regulatory body responsible for ensuring the safety, quality, and performance of food, drugs, and medical devices sold or distributed in the Kingdom. The Saudi food and drug authority regulates medical devices under its Medical Devices Sector (MDS) and requires a Medical Device Marketing Authorization (MDMA) for all devices before they can be marketed in Saudi Arabia.
Yes. All medical devices and IVDs — regardless of risk class — must obtain MDMA approval from the SFDA before being imported, sold, or distributed in Saudi Arabia. There are no exemptions. Operating without SFDA approval is a legal violation that can result in product seizure, financial penalties, and market bans.
 
No. Since January 2022 and the introduction of the MDMA2 (Saudi Route), prior approval from reference countries like the EU or USA is no longer a requirement for SFDA registration. However, existing CE Marking documentation significantly supports your clinical evaluation and technical file. Traccglobal leverages your CE/FDA documentation to reduce Saudi registration costs and timelines.
Timelines depend on device class and documentation completeness. Class A: 2–4 months. Class B: 4–6 months. Class C: 6–9 months. Class D: 9–14 months. The official SFDA review period is 35 working days, but actual timelines are longer due to query rounds. Traccglobal’s thorough first-submission approach minimises queries and accelerates the overall process significantly.
 
The GHAD portal is the SFDA’s official electronic system for submitting medical device marketing authorization applications. All MDMA submissions, document uploads, fee payments, and query responses are managed through GHAD. Your Authorized Representative (AR) must have a GHAD account to submit on your behalf. Traccglobal manages the complete GHAD submission process — you never need to interact with the portal directly.
Yes — it is mandatory. Any foreign manufacturer without a legal entity in Saudi Arabia must appoint a licensed Authorized Representative (AR) who holds an annual-renewable AR license from the SFDA. The AR submits your application, communicates with the Saudi food and drug authority, and handles all post-market regulatory obligations in the Kingdom. Traccglobal provides verified AR partnerships in Saudi Arabia as part of our medical device regulatory support services.
SFDA registration fees vary by device class and application type. Government fees for MDMA applications are assessed after the initial completeness review. In addition, you will need to account for AR license costs (annual renewal), translation costs for Arabic labeling, and professional consultancy fees. Traccglobal provides a transparent, all-inclusive cost estimate during your free initial consultation — no hidden charges.
Under the MDMA2 (Saudi Route), SFDA certificates are valid for 3 years. Renewal must be initiated before the certificate expires. Traccglobal provides proactive renewal tracking and manages the renewal submission process on your behalf, ensuring no lapse in your market authorization.
Yes. ISO 13485 QMS certification is a mandatory requirement for SFDA registration across all device classes. Traccglobal provides integrated support — from ISO 13485 implementation and certification to full SFDA TFA preparation, AR services, GHAD portal submissions, and post-market compliance. We are your single point of contact for everything.
Post-market obligations are ongoing and enforced by the SFDA. Manufacturers must submit Periodic Safety Update Reports (PSUR) — annually for Class C and D, every 2 years for Class B. Class D devices also require a Summary of Safety and Clinical Performance (SSCP). All adverse events and field safety notices must be reported to the National Centre for Medical Devices Registration (NCMDR). UDI compliance must be maintained. Traccglobal handles all of these ongoing obligations so your SFDA registration stays active and compliant.

Our Services

Let Us Know Your Requirements

Call Emergency
+918868886774

Testimonials

What Our Clients Says

Real feedback from our happy clients about our quality and service.

"The team delivered our turnkey project on time with exceptional quality. Their professionalism and technical expertise exceeded our expectations."
Rajesh Sharma
Rajesh SharmaOperations Manager
"Their support in implementing our Quality Management System was outstanding. The documentation and compliance process became smooth and hassle-free."
Priya Mehta
Priya MehtaQuality Head
"Excellent coordination and execution in our product installation and after-sales support. Great experience working with them."
Vikram Singh
Vikram SinghProject Engineer